173 related articles for article (PubMed ID: 37745306)
1. Anti-inflammatory effect of interleukin-6 highly enriched in secretome of two clinically relevant sources of mesenchymal stromal cells.
Dedier M; Magne B; Nivet M; Banzet S; Trouillas M
Front Cell Dev Biol; 2023; 11():1244120. PubMed ID: 37745306
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory priming enhances mesenchymal stromal cell secretome potential as a clinical product for regenerative medicine approaches through secreted factors and EV-miRNAs: the example of joint disease.
Ragni E; Perucca Orfei C; De Luca P; Mondadori C; Viganò M; Colombini A; de Girolamo L
Stem Cell Res Ther; 2020 Apr; 11(1):165. PubMed ID: 32345351
[TBL] [Abstract][Full Text] [Related]
3. IL-1β-Primed Mesenchymal Stromal Cells Improve Epidermal Substitute Engraftment and Wound Healing via Matrix Metalloproteinases and Transforming Growth Factor-β1.
Magne B; Dedier M; Nivet M; Coulomb B; Banzet S; Lataillade JJ; Trouillas M
J Invest Dermatol; 2020 Mar; 140(3):688-698.e21. PubMed ID: 31513805
[TBL] [Abstract][Full Text] [Related]
4. Effect of pro-inflammatory cytokine priming and storage temperature of the mesenchymal stromal cell (MSC) secretome on equine articular chondrocytes.
Jammes M; Contentin R; Audigié F; Cassé F; Galéra P
Front Bioeng Biotechnol; 2023; 11():1204737. PubMed ID: 37720315
[No Abstract] [Full Text] [Related]
5. Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming.
Redondo-Castro E; Cunningham CJ; Miller J; Brown H; Allan SM; Pinteaux E
Stem Cell Res Ther; 2018 Jan; 9(1):11. PubMed ID: 29343288
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro.
Redondo-Castro E; Cunningham C; Miller J; Martuscelli L; Aoulad-Ali S; Rothwell NJ; Kielty CM; Allan SM; Pinteaux E
Stem Cell Res Ther; 2017 Apr; 8(1):79. PubMed ID: 28412968
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric analysis of the in vitro secretome from equine bone marrow-derived mesenchymal stromal cells to assess the effect of chondrogenic differentiation on response to interleukin-1β treatment.
Bundgaard L; Stensballe A; Elbæk KJ; Berg LC
Stem Cell Res Ther; 2020 May; 11(1):187. PubMed ID: 32434555
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cell-derived secretome enhances nucleus pulposus cell metabolism and modulates extracellular matrix gene expression
Tilotta V; Vadalà G; Ambrosio L; Cicione C; Di Giacomo G; Russo F; Papalia R; Denaro V
Front Bioeng Biotechnol; 2023; 11():1152207. PubMed ID: 37008028
[No Abstract] [Full Text] [Related]
9. Dissecting the effects of preconditioning with inflammatory cytokines and hypoxia on the angiogenic potential of mesenchymal stromal cell (MSC)-derived soluble proteins and extracellular vesicles (EVs).
Gorgun C; Ceresa D; Lesage R; Villa F; Reverberi D; Balbi C; Santamaria S; Cortese K; Malatesta P; Geris L; Quarto R; Tasso R
Biomaterials; 2021 Feb; 269():120633. PubMed ID: 33453634
[TBL] [Abstract][Full Text] [Related]
10. TNF-α and IL-1β-activated human mesenchymal stromal cells increase airway epithelial wound healing in vitro via activation of the epidermal growth factor receptor.
Broekman W; Amatngalim GD; de Mooij-Eijk Y; Oostendorp J; Roelofs H; Taube C; Stolk J; Hiemstra PS
Respir Res; 2016 Jan; 17():3. PubMed ID: 26753875
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of the secretome of human bone marrow-derived mesenchymal stem cells primed by pro-inflammatory cytokines.
Maffioli E; Nonnis S; Angioni R; Santagata F; Calì B; Zanotti L; Negri A; Viola A; Tedeschi G
J Proteomics; 2017 Aug; 166():115-126. PubMed ID: 28739509
[TBL] [Abstract][Full Text] [Related]
12. Human multipotent mesenchymal stromal cells cytokine priming promotes RAB27B-regulated secretion of small extracellular vesicles with immunomodulatory cargo.
Cheng A; Choi D; Lora M; Shum-Tim D; Rak J; Colmegna I
Stem Cell Res Ther; 2020 Dec; 11(1):539. PubMed ID: 33317598
[TBL] [Abstract][Full Text] [Related]
13. Immunoregulatory potential of mesenchymal stem cells following activation by macrophage-derived soluble factors.
Saldaña L; Bensiamar F; Vallés G; Mancebo FJ; García-Rey E; Vilaboa N
Stem Cell Res Ther; 2019 Feb; 10(1):58. PubMed ID: 30760316
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Dendritic Cell Maturation and Function.
Reis M; Mavin E; Nicholson L; Green K; Dickinson AM; Wang XN
Front Immunol; 2018; 9():2538. PubMed ID: 30473695
[TBL] [Abstract][Full Text] [Related]
15. Exosomes from IL-1β-Primed Mesenchymal Stem Cells Inhibited IL-1β- and TNF-α-Mediated Inflammatory Responses in Osteoarthritic SW982 Cells.
Kim M; Shin DI; Choi BH; Min BH
Tissue Eng Regen Med; 2021 Aug; 18(4):525-536. PubMed ID: 33495946
[TBL] [Abstract][Full Text] [Related]
16. Amniotic membrane-mesenchymal stromal cells secreted factors and extracellular vesicle-miRNAs: Anti-inflammatory and regenerative features for musculoskeletal tissues.
Ragni E; Papait A; Perucca Orfei C; Silini AR; Colombini A; Viganò M; Libonati F; Parolini O; de Girolamo L
Stem Cells Transl Med; 2021 Jul; 10(7):1044-1062. PubMed ID: 33656805
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal Stromal Cells and Their Secretome: New Therapeutic Perspectives for Skeletal Muscle Regeneration.
Sandonà M; Di Pietro L; Esposito F; Ventura A; Silini AR; Parolini O; Saccone V
Front Bioeng Biotechnol; 2021; 9():652970. PubMed ID: 34095095
[TBL] [Abstract][Full Text] [Related]
18. Extracellular Vesicles Isolated from Mesenchymal Stromal Cells Primed with Hypoxia: Novel Strategy in Regenerative Medicine.
Pendse S; Kale V; Vaidya A
Curr Stem Cell Res Ther; 2021; 16(3):243-261. PubMed ID: 32957892
[TBL] [Abstract][Full Text] [Related]
19. The effect of Trimetazidine and Diazoxide on immunomodulatory activity of human embryonic stem cell-derived mesenchymal stem cell secretome.
Jahandideh S; Maghsood F; Ghahhari NM; Lotfinia M; Mohammadi M; Johari B; Kadivar M
Tissue Cell; 2017 Oct; 49(5):597-602. PubMed ID: 28843336
[TBL] [Abstract][Full Text] [Related]
20. Immunological priming of mesenchymal stromal/stem cells and their extracellular vesicles augments their therapeutic benefits in experimental graft-versus-host disease
Hackel A; Vollmer S; Bruderek K; Lang S; Brandau S
Front Immunol; 2023; 14():1078551. PubMed ID: 36875112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
